Navigation Links
NEW DATA FOR PAZOPANIB - GSK'S LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS
Date:5/31/2008

Two Phase II studies demonstrated potential for pazopanib as a single agent treatment for early stage non-small cell lung cancer and advanced renal cell cancer:

-- In patients with stage I-III non-small cell lung cancer, 86 percent of

patients who received pazopanib monotherapy experienced a reduction in

tumor volume

-- In patients with advanced renal cell cancer, there was an overall

response rate of 35 percent. The median duration of response was longer

than 16 months (68 weeks) and the median progression-free survival was

11.9 months

LONDON and PHILADELPHIA, May 31 /PRNewswire-USNewswire/ -- GlaxoSmithKline today announced the results of two Phase II trials demonstrating the potential for pazopanib, an oral, investigational angiogenesis inhibitor, as a treatment for non-small cell lung cancer (NSCLC),(1) the most common form of lung cancer,(2) and renal cell carcinoma (RCC).(3) The data were presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Pazopanib is not approved in any market for any indication at this time.

Pazopanib targets vascular endothelial growth factor receptor (VEGFR), platelet derived growth factor receptor (PDGFR) and c-kit, key proteins that help with the growth of new blood vessels in the body.(4) This process, known as angiogenesis, plays a critical role in the growth and spread of tumors(5).

"These very promising results highlight the potential of pazopanib as a future treatment option across multiple forms of cancer," said Thierry Le Chevalier, M.D., Vice President, Oncology Medicine Development Center, GSK. "GSK is conducting a broad research program for pazopanib in a number of tumor types and this demonstrates our ongoing commitment to the development of innovative and effective treatments for patients with cancer."

Pazopanib and Non-Small Cell Lung Cancer: abstract 7557 (1)

DATA
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
2. Scientists, physicians present latest findings in personalized cancer treatment and prevention
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Health psychologists discuss latest research findings
5. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
6. PA Governor Rendell Announces Latest Nominations and Appointments
7. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
8. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
9. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
10. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
11. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... November 23, 2014 Cancer researchers in ... connection between intercellular communication tunnels and the growth and ... full story on the Surviving Mesothelioma website. ... the University of Minnesota have just released their study ... and materials between cells. They found that mesothelioma ...
(Date:11/22/2014)... UWDress.com, a successful wedding dress shop, has released its new ... to prepare for the wedding season. All of them are ... UWDress.com is a reliable company that has many years of ... -- formal wedding guest attire. This new collection comes in ... princess. As one of the leading companies in the wedding ...
(Date:11/22/2014)... Recently, Locks-Magnetic.com , one of the successful electrical ... locks for glass doors online. In addition, the company ... products. Customers can get more information on its website. ... excellent performance. Customers who want to buy this new ... They also can enjoy the one-stop shopping experience. ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding ... the business offers a wide range of special occasion ... allowing them to create multiple looks easily. , According ... collection of chic wedding dresses has been prepared for ... discounted rates now. Dylan Queen can always create what ...
(Date:11/22/2014)... “Due to my knee replacement surgery, I ... Ill. “While using the ice grip attachment, I noticed how ... needed to be a safer way to prevent possible injuries, ... The SPIKE BLOCK offers added safety and stability in slick ... reduce injuries and damage associated with traditional spiked ice grips. ...
Breaking Medicine News(10 mins):Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Discounted Mag Locks for Glass Doors Revealed by Locks-Magnetic.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2
... Ohio, April 7, 2008 Chemical Abstracts,Service (CAS) ... SciFinder research,tool. CAS announced and demonstrated the new ... in New Orleans, April 6, 2008., (Logo: ... find using the new version of SciFinder an,important ...
... Put Medical Equipment Providers Out of Business and,Disrupt Services ... Dallas Area;, Austin, Beaumont, El Paso, Houston, McAllen, ... 7, 2008 A new Medicare,bidding program for durable ... Worth metropolitan area on July 1, 2008, will,put many ...
... finds olanzapine changes metabolism in weeks , , MONDAY, April ... olanzapine may put a person at an increased risk ... show. , A team of French researchers studying the ... olanzapine over several weeks, the rodents, blood sugar ...
... Health Record to actively engage diabetes patients in their ... levels, better vaccination compliance and increased tobacco cessation rates, ... Health System launched an Electronic Health Record-driven care program ... published in Aprils Journal of General Internal Medicine showed ...
... Cons of Approach to Eliminating HAIs, ORLANDO, Fla., ... drive to eliminate infections acquired in hospitals -,is provoking ... the approach is overly simplistic and potentially dangerous to,praise ... experts will,discuss the hot-button issue at the Annual Meeting ...
... The critical lack of,family and paraprofessional caregivers ... renewal of the Community College Caregiver Training,Initiative for ... Foundation, The Caregiving Project for Older,Americans, a project ... a Request for Proposals (RFP) and will award ...
Cached Medicine News:Health News:CAS' New SciFinder(R) Enhances the Research Experience Via the Web 2Health News:Medicare Bidding Program for Dallas, Texas is Rife with Errors, Says American Association for Homecare 2Health News:Medicare Bidding Program for Dallas, Texas is Rife with Errors, Says American Association for Homecare 3Health News:Antipsychotic Drug Boosts Risk of Heart Disease, Diabetes 2Health News:Geisinger improves care for thousands of diabetics through use of the Electronic Health Record 2Health News:The 'Zero' Mentality: Is It Good for Infection Control? 2Health News:ILC-USA and MetLife Foundation Launch Second Year of Community College Caregiver Training Grants 2
(Date:11/21/2014)... YORK , Nov. 20, 2014  Market research firm ... the "Year of The Buy, in the medical device ... for medical devices will produce just 3% growth this ... actions, including acquisitions of product lines and entrance by ... annual survey of medical devices, The Global Market ...
(Date:11/21/2014)... 20, 2014  The acceptance of two abstracts ... Global Congress demonstrates continued interest in the Eclipse ... bowel control. One of the abstracts, presented by ... Chief of Urogynecology and Reconstructive Pelvic Surgery at ... for Best Written Abstract on Urogynecology/Pelvic Floor Disorders/Vaginal ...
(Date:11/21/2014)... 2014 Oxis International, Inc. (OXIS) (OXI.PA) announced today ... Anthony J. Cataldo as Chief Executive Officer, and ... 19, 2014, Ken Eaton resigned his positions as ... of Oxis International, Inc. to pursue new opportunities. ... Executive Officer of Oxis International, Inc. Mr. Cataldo will continue ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
... Oct. 4 In response to the ... importance of "aging-in-place" as an alternative solution ... ("Delta") today announced the introduction of ClinicalVirtuoso™ ... optimize the homecare therapist. (Logo: ...
... CITY, Mo., Oct. 4 A new study by ... in Kansas City, Mo., found that rapid electronic review ... away allowed for earlier diagnosis and treatment of potentially ... the American Academy of Pediatrics National Conference and Exhibition ...
Cached Medicine Technology:Delta Health Technologies ClinicalVirtuoso™ Targets Homecare Therapists 2New Study Shows Telemedicine Works to Effectively Identify Heart Problems in Children Far from a Specialized Medical Center 2
... integrates drug infusion,with patient monitoring and ... modular platform. With multiple configuration,options, you ... you,need them, keeping the number of ... while managing the unique needs of,each ...
... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
... of the first steps any hospital or ... the most powerful, most effective tools available ... CliniComps world-class clinician documentation and electronic medical ... systems achieve this goal. In fact, its ...
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
Medicine Products: